The Faculty of Pharmacy at University of Basrah organized a scientific symposium (stability of pharmaceuticals in different circumstances) with the participation of researchers And specialists. Where the seminar included scientific lectures, the first of which was for Dr. Ahmed Najm Abboud, in which the stability of pharmaceuticals The second lecture was for Dr. Mohammed Sabbar Abdul Ridha. In it he touched on a number of facts concerning the safety and effectiveness of the drug after the expiry date and was the third lecture of the doctor The pilgrims explained the variables in pharmaceuticals at the molecular level and the nature and behavior of the drug molecules during After the validity period, Dr. Noire Adai addressed in his lecture everything related to the stability of pharmaceuticals manufactured on The form of powder, which must be solved before use as antibiotics and the accompanying changes in this process, was the last lecture Dr. Abdul Razzaq Hamid included the legislation and studies that are implemented when manufacturing medicines related to the stability of preparations. Pharmaceutical. The aim of the seminar was to discuss a number of issues related to the stability of the drug in different circumstances, which guarantee the arrival of a drug Patient security and effectiveness. The symposium recommended the need to emphasize participation between different pharmaceutical sectors to identify problems Related to the stability and stability of treatment during the validity of treatment and after the expiry period of the treatment as well as the increase of professional awareness between sectors Different health and community awareness regarding the safety and effectiveness of treatment during the validity period through the holding of conferences and seminars And workshops. In addition to the need to abide by the instructions and publications that contribute to the increase of professional and community awareness in relation to the preservation of Pharmaceuticals in addition to careful preservation of medicines in the right conditions to ensure their safety and effectiveness and the issuance of new legislation Ensures close scrutiny of problems that threaten the safety and effectiveness of treatment and obliges producing companies to provide accurate information And detailed on what the correct combination of drugs
